PRAGUE; March 5 2025 / PRNEWSWIRE/-Emface, revolutionary non-invasive face treatment, has reached an excellent milestone-with the fastest process of this kind to exceed 1 million treatments worldwide in less than two years. This achievement of Emface cement as the leading non -invasive face -to -face process designed to treat both skin and underlying muscles for a more youthful, elevated appearance.
Developed by BTL, a world leader in medical technology, Emface transformed the industry in 2022 as the first independent operator process to avoid confirming facial muscles while at the same time improving skin quality.
“The ability to stimulate the lift muscles allows us to lift facial features from the inside that was never possible before injectable or traditional energy-based devices.” said Dr. Yael halaasA New York face plastic surgeon, USA.
Without needles, vacations or discomfort, Emface has gained widespread recognition both between medical professionals and patients, leading its rapid adoption around the world.
Innovation at the forefront of success
In the past year, Emface has expanded its potential with the introduction of specialized subjects and applications below the eyes, making treatment even more flexible. The latest eye apps have overwhelmingly received positive feedback from medical experts while launching at the IMCAS World Conference at Paris in January 2025.
“Emface is not just a process-it is a multi-faceted face that allows us to deal with different areas based on the unique needs of each patient. Added by Dr. Kyungkook Hong, a certified dermatologist by the Board of Directors by Seoul, Korea.
Worldwide expansion and impact on industry
Emface continues to gain momentum, with more professionals integrating it into their treatment offers. Its ability to complement the injectables makes it a key element of integrated facial rejuvenation plans, providing patients a non -invasive solution for improved results.
“Achieving 1 million therapies in just two years is proof of Emface’s innovative technology and the value it brings to medical professionals.” said ThomasCEO of BTL. “We remain committed to expanding this platform and further promoting non -invasive facial treatments in the coming years.”
For more information about Emface and its revolutionary technology, visit www.emface.com.
About BTL
Founded in 1993, BTL has been developed to become one of the world’s leading medical equipment manufacturers. With 500+ engineers and 3,000+ employees in more than 80 countries, BTL offers advanced non -invasive solutions for body configuration, forged and other medical aesthetic remedies, including their health and mental well -being. Among other brands, BTL products include EMSCULPT NEO®Emface®Exion ™, EMSELLA®Exomind ™ as well as their own HIFEM®HIFES ™ and Exotms ™ procedures. Please visit www.btlaesthetics.com For additional information.
